2024 Roundup

2024 Roundup

As we begin the new year, take a look at some of our top content from 2024...


Blog | Nitrosamines in small molecule API development

Nitrosamines in small molecule API development

In recent years, there has been an intense focus on eliminating and mitigating nitrosamines in API development and manufacturing, due to a series of recalls and regulatory initiatives. Click to learn more.

Authored by Adrian Smith, CR&D Principal Scientist.


Whitepaper | An ammonia-based approach to chilling for pharmaceutical manufacturing

Ammonia based chiller

As a critical component of pharmaceutical manufacturing, cooling technology aids in controlling process temperatures, keeping equipment in good working order and maintaining environmental conditions on-site.

Click to read more.


Blog | Maintaining quality and compliance in API manufacturing

Maintaining quality and compliance in API manufacturing graphic

In this Journey of an API blog, OQ Department Manager, Donna Anderson, discusses the role of quality control and quality assurance in API manufacturing, whilst also defining the key goals and strategies for success.

Click to find out more.


Whitepaper | Advancements and methods in peptide drug development

Peptide whitepaper graphic

In this whitepaper, Tom Kiely, Senior Process Engineer, considers the advances and core use cases for peptides in the pharmaceutical space. Click to discover more.

Authored by Tom Kiely, Senior Process Engineer.


Infographic | Measurement of ADC Stability in Plasma and Serum via Mass Spectrometry Analysis

Measurement of ADC stability in plasma and serum via mass spectrometry analysis

Stability of biologics is a critical quality attribute affecting levels of dosing and efficacy, however measuring it can be complicated. Mass spectrometry approaches can be used for measuring ADC stability with varying levels of sample processing. Click to learn more.

Authored by Chris Nortcliffe, Mass Spectrometry Manager, and Colin McKee, Head of Technical Services.


Blog | Supporting complex syntheses with automated specialized reactors and high-integrity data

Supporting complex syntheses with automated specialised reactors

In this blog, Chemical Research and Development Chemist, Tia Jarvis, Ph.D., discusses how reactor data can aid in mitigating risk and optimising reactor conditions. Click to read more.

Authored by Tia Jarvis, CR&D Scientist.


Whitepaper | An efficient approach to process optimisation

Design of experiments graphic

Take a closer look at the advantages of DOE, as well as how we can harness it to navigate complex processes. Click to find out more.

Authored by Shawn Dormann, Research Scientist, Nicholas Kramer, Senior Research Scientist, and Annie Wilt, Analytical Scientist.


Upcoming events →

?? JP Morgan, 2025 Healthcare Conference | San Francisco, US | 13th - 16th January

?? Lunch and Learn | Pennsylvania Biotechnology Center (PABC) | 28th January

?? World ADC Europe | London, UK | 3rd - 6th March

?? Bio-Europe Spring | Milan, Italy | 17th - 19th March

?? DCAT Week | New York, US | 17th - 20th March

?? CPhI North America | Philadelphia, US | 20th - 22nd May




要查看或添加评论,请登录

Sterling Pharma Solutions的更多文章

社区洞察

其他会员也浏览了